Biopharmaceutical Development

DeepCyte Launches World’s First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma Pilots Advance

Yuvraj — Wed, 19 Aug 2026 09:18:39 +0000

Proprietary training dataset spanning 300,000 cells and ~100 compounds positions DeepCyte to transform preclinical toxicology with mechanism-based prediction DeepCyte Inc., a techbio company building AI toxicology tools for drug development, today announced the launch of DeeTox Atlas™, the world’s first single-cell metabolomic reference atlas of drug toxicity mechanisms. Enterprise pilot programs with global pharmaceutical companies […]

The post DeepCyte Launches World’s First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma Pilots Advance first appeared on World Pharma Today.

Telangana Aims to Emerge as India’s Life Sciences Innovation Capital with $25B Investment Target by 2030

Yuvraj — Tue, 18 Aug 2026 12:16:50 +0000

Strengthening Domestic API Depth and Reducing Import Reliance Key to Global Competitiveness Reaching $300B Valuation Demands Rapid Innovation, Biologics Scale, and Sustainable Quality Standards” True Advantage Beyond Cost: Innovation and Global Regulatory Excellence Must Drive India’s Next Pharma Phase” As India sets an ambitious roadmap to reach a USD 130 billion pharmaceutical market valuation by […]

The post Telangana Aims to Emerge as India’s Life Sciences Innovation Capital with $25B Investment Target by 2030 first appeared on World Pharma Today.

CPHI Launches New Sustainability Summit as Pharma Faces Growing Pressure to Deliver Sustainability Goals

Yuvraj — Thu, 13 Aug 2026 06:49:27 +0000

CPHI has announced the launch of the CPHI Sustainability Summit, a new two-day event dedicated to advancing sustainability across the pharmaceutical value chain. Taking place at Fiera Milano, Italy, on 5-6 October 2026, alongside CPHI Milan, the summit will bring together more than 300 sustainability leaders, pharmaceutical executives and supply chain stakeholders to discuss practical action on one of […]

The post CPHI Launches New Sustainability Summit as Pharma Faces Growing Pressure to Deliver Sustainability Goals first appeared on World Pharma Today.

Daewoong and Chime Biologics Partner for Biosimilar Push

Yuvraj — Wed, 10 Jun 2026 12:09:36 +0000

Chime Biologics and Daewoong Pharmaceutical have entered into a strategic collaboration to develop and manufacture a dupilumab biosimilar candidate referencing Dupixent for global markets. The partnership, announced by VMS Group, combines the development and manufacturing capabilities of Chime Biologics with Daewoong Pharmaceutical’s plans to expand its presence in the international biosimilars sector. Through this initiative, […]

The post Daewoong and Chime Biologics Partner for Biosimilar Push first appeared on World Pharma Today.

Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe

Yuvraj — Mon, 01 Jun 2026 05:48:10 +0000

Nestlé Health Science and IdB Holding have officially announced a VOWST licensing agreement to develop and commercialize the oral therapy in Europe, subject to approval by the European Medicines Agency (EMA). This collaboration aims to expand European patient access to therapies preventing recurrent Clostridioides difficile infection, a severe gastrointestinal condition with limited management options. Currently […]

The post Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe first appeared on World Pharma Today.

The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement

Yuvraj — Mon, 06 Apr 2026 08:17:20 +0000

Why Field Execution Must Evolve Field execution — how pharma companies organize, direct, and deliver commercial and medical interactions with healthcare professionals (HCPs), prescribers, and institutional decision-makers (collectively, “customers”) — is a major contributor to commercial success. Accordingly, over the past decade, companies have invested heavily in sales force effectiveness, key account management, omnichannel strategies, […]

The post The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement first appeared on World Pharma Today.

Excipients Innovation Transforming Drug Delivery Performance

Yuvraj — Wed, 11 Feb 2026 12:10:45 +0000

Analysis of the evolving role of functional excipients in modern pharmacology, moving beyond inert fillers to become active participants in drug stability and targeted release.

The post Excipients Innovation Transforming Drug Delivery Performance first appeared on World Pharma Today.

Sustainable Materials in Pharmaceutical Drug Delivery Systems

Yuvraj — Mon, 09 Feb 2026 09:49:33 +0000

Examination of the pharmaceutical industry's transition toward biodegradable polymers and eco-friendly excipients to reduce environmental impact while maintaining high therapeutic standards.

The post Sustainable Materials in Pharmaceutical Drug Delivery Systems first appeared on World Pharma Today.

Artificial Intelligence in Drug Formulation Development

Yuvraj — Mon, 09 Feb 2026 08:58:13 +0000

Investigation into the role of machine learning and predictive modeling in streamlining the optimization of pharmaceutical recipes and reducing the time-to-market for new therapies.

The post Artificial Intelligence in Drug Formulation Development first appeared on World Pharma Today.

Injectable Drug Formulation Trends in Biopharma

Yuvraj — Fri, 06 Feb 2026 13:10:50 +0000

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.

The post Injectable Drug Formulation Trends in Biopharma first appeared on World Pharma Today.